Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway
about
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancerThe role of the p38 MAPK signaling pathway in high glucose-induced epithelial-mesenchymal transition of cultured human renal tubular epithelial cellsA novel chordoma xenograft allows in vivo drug testing and reveals the importance of NF-κB signaling in chordoma biologyTumor-derived interleukin-1 promotes lymphangiogenesis and lymph node metastasis through M2-type macrophagesOsmoprotective transcription factor NFAT5/TonEBP modulates nuclear factor-kappaB activity.The expression of nuclear factor kappa B in inflammation-induced rat corneal neovascularization.Lymphatic vessels assessment in feline mammary tumours.Phosphorylation of cold shock domain/Y-box proteins by ERK2 and GSK3beta and repression of the human VEGF promoter.Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.Expression and function of heregulin-alpha and its receptors in the mouse mammary gland.IκB kinase β regulates epithelium migration during corneal wound healingFatty acid-binding protein 5 and PPARbeta/delta are critical mediators of epidermal growth factor receptor-induced carcinoma cell growthLymphangiogenesis and lymphatic metastasis in breast cancer.Overexpression of MEKK3 confers resistance to apoptosis through activation of NFkappaB.Heparanase promotes human gastric cancer cells migration and invasion by increasing Src and p38 phosphorylation expression.Vascular endothelial growth factor levels in relation to oxidative damage and antioxidant status in patients with breast cancer.Tumor necrosis factor-α promotes the lymphangiogenesis of gallbladder carcinoma through nuclear factor-κB-mediated upregulation of vascular endothelial growth factor-C.SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancerRadiogenic lymphangiogenesis in the skinIdentification of Gene Expression Differences between Lymphangiogenic and Non-Lymphangiogenic Non-Small Cell Lung Cancer Cell Lines.Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors.Increased lymphangiogenesis in joints of mice with inflammatory arthritisRASSF8 downregulation promotes lymphangiogenesis and metastasis in esophageal squamous cell carcinoma.The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.The non-canonical role of vascular endothelial growth factor-C axis in cancer progressionp38-MAPK/MSK1-mediated overexpression of histone H3 serine 10 phosphorylation defines distance-dependent prognostic value of negative resection margin in gastric cancer.Current insights on the biology and clinical aspects of VEGF regulation.Role of p38 MAP Kinase Signal Transduction in Solid TumorsLymphangiogenesis, myeloid cells and inflammation.Chitin hydrolysate stimulates VEGF-C synthesis by MDA-MB-231 breast cancer cells.Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells.Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis.Overexpression of AKIP1 promotes angiogenesis and lymphangiogenesis in human esophageal squamous cell carcinoma.The status of phosphorylated p38 in esophageal squamous cell carcinoma.Enzastaurin inhibits invasion and metastasis in lung cancer by diverse molecules.Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model.Quantitative proteomic and transcriptional analysis of the response to the p38 mitogen-activated protein kinase inhibitor SB203580 in transformed follicular lymphoma cells.Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation.Paeoniflorin inhibits proliferation of endometrial cancer cells via activating MAPK and NF-κB signaling pathways.Disrupted Balance of MMPs/TIMPs in Gastric Carcinogenesis-Paradoxical Low MMP-2 Expression in Tumor and Stromal Compartments as a Potential Marker of Unfavorable Outcome.
P2860
Q24651871-DE5834E7-798D-48B7-AA03-1B139CE0B8E3Q28476375-4117D3C5-1588-48C8-A136-ADE9A3C61385Q28534867-497967B0-1319-4ADA-8A02-91BB9A96C517Q28539655-DBE6213B-8D27-409B-AA8F-300E4844E6ADQ30496797-38416BCE-63BE-462E-9AC6-C6EAA2FAB86DQ33266202-BDFB8FC5-96F1-4397-B410-021494049BBEQ33269181-2110027F-1EF7-4662-8E4B-B610B61BD8F7Q33292543-3A44017A-29EB-4E22-BA7C-BAA1DE90CF47Q33597563-55FEE903-DB27-449F-8F87-D9A6A9221C93Q33686043-521C9E04-423D-4EC1-9DBB-234C80E5CC8EQ33802598-FB9133CC-CE9A-4D41-BB84-08416DEDED53Q33911239-61357458-08EE-466F-8D28-2E565593D51AQ33940058-6D151450-FA5A-4600-9BA1-AB4D8AA8857FQ34282044-3B4B27AD-4077-4F61-BC51-9748B0292BBEQ34371234-799444CA-5E48-4F3C-9E78-108C9FBA6220Q35435446-E3B190A1-5812-4255-9ED8-149843ED3D58Q35713318-B82AD6AB-1C48-4AEB-A503-6BBF6ED37A36Q35913687-B1FAC6CC-5EEC-4F62-B2DB-D07702D2BC2AQ35928217-B431C355-BBB3-4C84-B481-0160640330F2Q35947903-AF8F3A89-58BB-458A-AD91-8CC60F4EC366Q36198192-4BDDCDD2-8D27-4A5F-915C-6AF70419D8A4Q36465469-B6D4F951-A1CC-44C5-B072-0D130C01619EQ36544139-5F21E827-8B3C-46B4-B44D-D8B389667D1BQ36589860-3F0DB665-21F0-46D0-8B11-39ACC3127162Q37071029-453FC3C1-D902-4D60-BAB1-3E4382CA66F2Q37224063-CAE2D79E-3491-43B1-9BB3-DA2DCB6BDAE5Q37272329-483E5845-0F10-42DE-98C2-7B08B2E77BDAQ37392558-73DAFF46-F63B-4B0E-9A29-83301C8AFE58Q37754580-E572D5A4-AD35-4A15-8397-236E26E86E47Q38339742-232C0841-A18F-4DD3-9DAC-C4F4FDE405C9Q38750549-015B1ABD-808A-44B9-8FA9-28952A7E3843Q38892406-CF5612D8-9A11-4327-B9FC-F5E9A9C252E1Q39035373-F2C12143-7B34-4BA6-BB06-978193C8D99FQ39428879-747AFD1F-CA06-4876-9A16-3882E37FE099Q39663655-80DD2084-2EE4-4ED7-9AD4-4A9F3BC9B0E9Q39883496-F0C6204C-1015-4967-898C-0F150ECEC30AQ40550748-2E98DCF9-4B56-4DBF-8A54-0AB9E642FFF6Q40573463-867D1FBD-C92C-4564-B22E-AABD5CA90A75Q47133648-4BBD2EBD-940E-48E2-8B47-875D71429445Q52659990-74D3860A-7A58-446D-93A0-EDF4B5995ECC
P2860
Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Up-regulation of vascular endo ...... ctor-kappa B signaling pathway
@ast
Up-regulation of vascular endo ...... ctor-kappa B signaling pathway
@en
Up-regulation of vascular endo ...... ctor-kappa B signaling pathway
@nl
type
label
Up-regulation of vascular endo ...... ctor-kappa B signaling pathway
@ast
Up-regulation of vascular endo ...... ctor-kappa B signaling pathway
@en
Up-regulation of vascular endo ...... ctor-kappa B signaling pathway
@nl
altLabel
Up-regulation of Vascular Endo ...... AR FACTOR- B SIGNALING PATHWAY
@en
prefLabel
Up-regulation of vascular endo ...... ctor-kappa B signaling pathway
@ast
Up-regulation of vascular endo ...... ctor-kappa B signaling pathway
@en
Up-regulation of vascular endo ...... ctor-kappa B signaling pathway
@nl
P2093
P2860
P3181
P356
P1476
Up-regulation of Vascular Endo ...... AR FACTOR- B SIGNALING PATHWAY
@en
Up-regulation of vascular endo ...... ctor-kappa B signaling pathway
@en
P2093
Cheng-Wen Wu
Min-Liang Kuo
Ming-Tsan Lin
P.-W. Tsai
Pei-Wen Tsai
S.-G. Shiah
Shine-Gwo Shiah
P2860
P3181
P356
10.1074/JBC.M204863200
P407
P577
2002-12-05T00:00:00Z
2003-02-21T00:00:00Z